| abstract |
The present invention relates to a new crystalline polymorph B-52 form of atorvastatin hemicalcium salt [A [(3R, 5R) -7 - [3-phenyl-4 - [ (phenyl carbamoyl] -2- (4 -fluorophenyl) -5- (1-methyletliyl) -IH- pyrrole-1-yl] -3, 5-dihydroxy-heptanoic acid calcium salt (2:1)] , medicinal preparations containing the new polymorph form, process for the preparation thereof and the use of the new polymorph form for the preparation of medicinal products . |